Abstract
Data on daptomycin use in the pediatric setting are scanty. We conducted a multicenter, retrospective study on 46 children treated with intravenous daptomycin at a mean dosage of 7.0 mg/kg/d, for a median of 14 days. Three children had adverse events possibly related to daptomycin. The drug was overall well tolerated, even with prolonged treatment.
MeSH terms
-
Administration, Intravenous
-
Adolescent
-
Anti-Bacterial Agents / administration & dosage*
-
Anti-Bacterial Agents / adverse effects
-
Bacterial Infections / drug therapy*
-
Child
-
Child, Preschool
-
Daptomycin / administration & dosage*
-
Daptomycin / adverse effects
-
Drug-Related Side Effects and Adverse Reactions / epidemiology
-
Female
-
Humans
-
Infant
-
Infant, Newborn
-
Male
-
Retrospective Studies
Substances
-
Anti-Bacterial Agents
-
Daptomycin